Loading…
CompareOpen in Google Play
This app isn't in any of our charts yet.
The app now tells you when a newer version is available, so every calculation runs on the latest models. Fonts are bundled with the app, the privacy policy link has been fixed, and several small interface improvements.
The predictive tool for sarcoma pathologies
This app is meant to be used only by physicians and it is not meant to make clinical decisions (the clinical usefulness of the two models has not been tested) but to be used as an informative tool to improve the predictive capability of a physician. Two kinds of predictions are possible: - RPS: 5-year overall survival (OS) and 5-year disease-free survival (DFS) in primary resected retroperitoneal sarcoma (RPS) patients. . - STS: 5- and 10-year overall survival (OS) and cumulative incidence of distant metastasis (CCI of DM) in primary resected extremity STS patients.